The impact of the COVID-19 pandemic on the use of systemic therapy for patients diagnosed with cancer in England: A population-based study with a focus on breast and lung cancer
Changes in the delivery of SACT were largely driven by a reduction in the number of patients who were diagnosed with cancer in 2020. An increased proportion of breast cancer patients treated with SACT likely reflects the increased proportion of patients who were diagnosed with stage III and stage IV disease.
Authors
- David Dodwell (ORCID: https://orcid.org/0000-0001-8787-4904)
- Laura Webster
- Martine Bomb
- Emma Kipps (ORCID: https://orcid.org/0000-0002-4912-8502)
- Matthew Barclay (ORCID: https://orcid.org/0000-0003-1148-1922)
- Georgios Lyratzopoulos (ORCID: https://orcid.org/0000-0002-2873-7421)
- Sarah Lawton (ORCID: https://orcid.org/0000-0002-8909-2057)
- Katherine Thackray
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- Cancer Research UK (GB)
- University of Oxford (GB)
- NHS Digital (GB)
- National Cancer Registration Service (GB)
- University College London (GB)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.canep.2025.102806
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05